Effective July 1, 2020 the Alabama Medicaid Agency will remove prior authorization (PA) from Mometasone nasal spray (generic Nasonex) and Modafinil (generic Provigil). Brand Nasonex and Provigil will now require PA. They will also update the Preferred Drug List to reflect the quarterly updates. The updates can be found here.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.